C-X-C Chemokine Receptor Type 2 Market Report

Global and Region C-X-C Chemokine Receptor Type 2 Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：143
  • REPORT CODE：GMM904560
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of C-X-C Chemokine Receptor Type 2 market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of C-X-C Chemokine Receptor Type 2market, defines the market attractiveness level of C-X-C Chemokine Receptor Type 2 market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of C-X-C Chemokine Receptor Type 2 industry, describes the types of C-X-C Chemokine Receptor Type 2 market, the applications of major players and the market size, and deeply analyzes the current situation of the global C-X-C Chemokine Receptor Type 2 market and the development prospects and opportunities of C-X-C Chemokine Receptor Type 2 industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global C-X-C Chemokine Receptor Type 2 market in Chapter 13.

    By Player:

    • AstraZeneca Plc

    • Syntrix Biosystems Inc

    • Novartis AG

    • Dompe Farmaceutici SpA

    • GlaxoSmithKline Plc

    • ChemoCentryx Inc

    By Type:

    • DF-2755A

    • AZD-5069

    • PAC-G31P

    • SX-517

    • Others

    By End-User:

    • Cornary Artery Disease

    • Liver Transplant Rejection

    • Prostate Cancer

    • Pulmonary Inflammation

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 C-X-C Chemokine Receptor Type 2 Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 C-X-C Chemokine Receptor Type 2 Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 C-X-C Chemokine Receptor Type 2 Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 C-X-C Chemokine Receptor Type 2 Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise C-X-C Chemokine Receptor Type 2 Market Analysis and Outlook to 2022

    • 7.1 Global C-X-C Chemokine Receptor Type 2 Consumption (2017-2022)

    • 7.2 United States C-X-C Chemokine Receptor Type 2 Consumption (2017-2022)

    • 7.3 Europe C-X-C Chemokine Receptor Type 2 Consumption (2017-2022)

    • 7.4 China C-X-C Chemokine Receptor Type 2 Consumption (2017-2022)

    • 7.5 Japan C-X-C Chemokine Receptor Type 2 Consumption (2017-2022)

    • 7.6 India C-X-C Chemokine Receptor Type 2 Consumption (2017-2022)

    • 7.7 South Korea C-X-C Chemokine Receptor Type 2 Consumption (2017-2022)

    8 Region and Country-wise C-X-C Chemokine Receptor Type 2 Market Analysis and Outlook to 2028

    • 8.1 Global C-X-C Chemokine Receptor Type 2 Consumption Forecast (2022-2028)

    • 8.2 United States C-X-C Chemokine Receptor Type 2 Consumption Forecast (2022-2028)

    • 8.3 Europe C-X-C Chemokine Receptor Type 2 Consumption Forecast (2022-2028)

    • 8.4 China C-X-C Chemokine Receptor Type 2 Consumption Forecast (2022-2028)

    • 8.5 Japan C-X-C Chemokine Receptor Type 2 Consumption Forecast (2022-2028)

    • 8.6 India C-X-C Chemokine Receptor Type 2 Consumption Forecast (2022-2028)

    • 8.7 South Korea C-X-C Chemokine Receptor Type 2 Consumption Forecast (2022-2028)

    9 Global C-X-C Chemokine Receptor Type 2 Market Outlook by Types and Applications to 2022

    • 9.1 Global C-X-C Chemokine Receptor Type 2 Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global DF-2755A Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global AZD-5069 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global PAC-G31P Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global SX-517 Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global C-X-C Chemokine Receptor Type 2 Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Cornary Artery Disease Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Liver Transplant Rejection Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Prostate Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Pulmonary Inflammation Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Global C-X-C Chemokine Receptor Type 2 Market Outlook by Types and Applications to 2028

    • 10.1 Global C-X-C Chemokine Receptor Type 2 Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global DF-2755A Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global AZD-5069 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global PAC-G31P Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global SX-517 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global C-X-C Chemokine Receptor Type 2 Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Cornary Artery Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Liver Transplant Rejection Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Pulmonary Inflammation Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global C-X-C Chemokine Receptor Type 2 Import and Export Analysis (Top 5 Countries)

    • 11.1 Global C-X-C Chemokine Receptor Type 2 Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global C-X-C Chemokine Receptor Type 2 Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 C-X-C Chemokine Receptor Type 2 Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global C-X-C Chemokine Receptor Type 2 Market Competitive Analysis

    • 14.1 AstraZeneca Plc

      • 14.1.1 AstraZeneca Plc Company Details

      • 14.1.2 AstraZeneca Plc C-X-C Chemokine Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 AstraZeneca Plc C-X-C Chemokine Receptor Type 2 Product and Service

    • 14.2 Syntrix Biosystems Inc

      • 14.2.1 Syntrix Biosystems Inc Company Details

      • 14.2.2 Syntrix Biosystems Inc C-X-C Chemokine Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Syntrix Biosystems Inc C-X-C Chemokine Receptor Type 2 Product and Service

    • 14.3 Novartis AG

      • 14.3.1 Novartis AG Company Details

      • 14.3.2 Novartis AG C-X-C Chemokine Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Novartis AG C-X-C Chemokine Receptor Type 2 Product and Service

    • 14.4 Dompe Farmaceutici SpA

      • 14.4.1 Dompe Farmaceutici SpA Company Details

      • 14.4.2 Dompe Farmaceutici SpA C-X-C Chemokine Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Dompe Farmaceutici SpA C-X-C Chemokine Receptor Type 2 Product and Service

    • 14.5 GlaxoSmithKline Plc

      • 14.5.1 GlaxoSmithKline Plc Company Details

      • 14.5.2 GlaxoSmithKline Plc C-X-C Chemokine Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 GlaxoSmithKline Plc C-X-C Chemokine Receptor Type 2 Product and Service

    • 14.6 ChemoCentryx Inc

      • 14.6.1 ChemoCentryx Inc Company Details

      • 14.6.2 ChemoCentryx Inc C-X-C Chemokine Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 ChemoCentryx Inc C-X-C Chemokine Receptor Type 2 Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of C-X-C Chemokine Receptor Type 2

    • Figure C-X-C Chemokine Receptor Type 2 Picture

    • Table Global C-X-C Chemokine Receptor Type 2 Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global C-X-C Chemokine Receptor Type 2 Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global C-X-C Chemokine Receptor Type 2 Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global C-X-C Chemokine Receptor Type 2 Consumption by Country (2017-2022)

    • Figure United States C-X-C Chemokine Receptor Type 2 Consumption and Growth Rate (2017-2022)

    • Table Europe C-X-C Chemokine Receptor Type 2 Consumption and Growth Rate (2017-2022)

    • Figure China C-X-C Chemokine Receptor Type 2 Consumption and Growth Rate (2017-2022)

    • Figure Japan C-X-C Chemokine Receptor Type 2 Consumption and Growth Rate (2017-2022)

    • Figure India C-X-C Chemokine Receptor Type 2 Consumption and Growth Rate (2017-2022)

    • Figure South Korea C-X-C Chemokine Receptor Type 2 Consumption and Growth Rate (2017-2022)

    • Figure Global C-X-C Chemokine Receptor Type 2 Consumption Forecast by Country (2022-2028)

    • Figure United States C-X-C Chemokine Receptor Type 2 Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe C-X-C Chemokine Receptor Type 2 Consumption Forecast and Growth Rate (2022-2028)

    • Figure China C-X-C Chemokine Receptor Type 2 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan C-X-C Chemokine Receptor Type 2 Consumption Forecast and Growth Rate (2022-2028)

    • Figure India C-X-C Chemokine Receptor Type 2 Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea C-X-C Chemokine Receptor Type 2 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global DF-2755A Consumption and Growth Rate (2017-2022)

    • Figure Global AZD-5069 Consumption and Growth Rate (2017-2022)

    • Figure Global PAC-G31P Consumption and Growth Rate (2017-2022)

    • Figure Global SX-517 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Cornary Artery Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Liver Transplant Rejection Consumption and Growth Rate (2017-2022)

    • Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Pulmonary Inflammation Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global DF-2755A Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global AZD-5069 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global PAC-G31P Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global SX-517 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cornary Artery Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Liver Transplant Rejection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pulmonary Inflammation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global C-X-C Chemokine Receptor Type 2 Import by Region (Top 5 Countries) (2017-2028)

    • Table Global C-X-C Chemokine Receptor Type 2 Export by Region (Top 5 Countries) (2017-2028)

    • Table AstraZeneca Plc (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Plc C-X-C Chemokine Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Plc C-X-C Chemokine Receptor Type 2 Product and Service

    • Table Syntrix Biosystems Inc (Foundation Year, Company Profile and etc.)

    • Table Syntrix Biosystems Inc C-X-C Chemokine Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Syntrix Biosystems Inc C-X-C Chemokine Receptor Type 2 Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG C-X-C Chemokine Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG C-X-C Chemokine Receptor Type 2 Product and Service

    • Table Dompe Farmaceutici SpA (Foundation Year, Company Profile and etc.)

    • Table Dompe Farmaceutici SpA C-X-C Chemokine Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dompe Farmaceutici SpA C-X-C Chemokine Receptor Type 2 Product and Service

    • Table GlaxoSmithKline Plc (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Plc C-X-C Chemokine Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Plc C-X-C Chemokine Receptor Type 2 Product and Service

    • Table ChemoCentryx Inc (Foundation Year, Company Profile and etc.)

    • Table ChemoCentryx Inc C-X-C Chemokine Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)

    • Table ChemoCentryx Inc C-X-C Chemokine Receptor Type 2 Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US